CRIPTO3 and type 2 diabetes mellitus: In agreement with our results, monocytes from patients with T2D with poor glycaemic control showed a reduced ability to associate with Mtb H37Rv, an effect attributed at least in part to alterations in complement receptors (CR3) or Fc-γ receptors (FcγRs) (Restrepo et al. 2014).